Skip to main content
Year archive

XTL Biopharmaceuticals Ltd. — 2026 filings

All 49 regulatory filings released by XTL Biopharmaceuticals Ltd. (XTLB) in 2026, sourced directly from the official regulator.

49 Filings
2026 Period
2026 filings (49)
Filing Released Lang
Receipt of Staff Delist Determination from Nasdaq
Delisting Announcement
2026-05-24 English
Receipt of Staff Delist Determination from Nasdaq
Report Publication Announcement
2026-05-24 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2026-05-22 English
Immediate Report of Meeting
Proxy Solicitation & Information Statement
2026-05-16 English
Immediate Report of Meeting
Proxy Solicitation & Information Statement
2026-05-16 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings
2026-05-15 English
Update regurding compliance with Nasdaq Listing Rule
Regulatory Filings
2026-05-07 Hebrew (modern)
Update regurding compliance with Nasdaq Listing Rule
Regulatory Filings
2026-05-07 Hebrew (modern)
6-K - XTL BIOPHARMACEUTICALS LTD (0001023549) (Filer)
Regulatory Filings
2026-05-07 English
Immediate Report
Regulatory Filings
2026-05-01 English
Immediate Report
Regulatory Filings
2026-05-01 English
Immediate Report
Regulatory Filings
2026-04-29 Hebrew (modern)
Immediate Report
Report Publication Announcement
2026-04-29 English
A report regarding XTL Biopharmaceuticals to Acquire Psyga Bio was published on EDGAR.
Report Publication Announcement
2026-04-29 Hebrew (modern)
6-K - XTL BIOPHARMACEUTICALS LTD (0001023549) (Filer)
Regulatory Filings
2026-04-29 English
3 - XTL BIOPHARMACEUTICALS LTD (0001023549) (Issuer)
Director's Dealing
2026-03-23 English
3 - XTL BIOPHARMACEUTICALS LTD (0001023549) (Issuer)
Director's Dealing
2026-03-23 English
Immediate Report
Share Issue/Capital Change
2026-03-20 English
Immediate Report
Report Publication Announcement FY 2026
2026-03-20 English
6-K - XTL BIOPHARMACEUTICALS LTD (0001023549) (Filer)
Regulatory Filings
2026-03-20 English
Immediate Report
M&A Activity
2026-03-10 English
Immediate Report
Report Publication Announcement
2026-03-10 English
Immediate Report
Delisting Announcement
2026-03-02 English
Immediate Report
Report Publication Announcement Q1 2026
2026-03-02 Hebrew (modern)
Immediate Report
Declaration of Voting Results & Voting Rights Announcements
2026-02-24 English
Immediate Report
Report Publication Announcement
2026-02-24 English
NASDAQ will not be implementing a trading halt in the Company's shares, therefore trading in its shares will be resumed.
Regulatory Filings
2026-02-24 English
suspension of trading until it is clarified whether NASDAQ , intends to suspend trading in its shares.
Regulatory Filings
2026-02-24 English
Immediate Report
Regulatory Filings
2026-02-23 English
Immediate Report
Report Publication Announcement
2026-02-23 English
Immediate Report
Earnings Release FY 2025
2026-02-19 English
Immediate Report
Regulatory Filings
2026-02-19 English
The Extraordinary General Meeting will be reconvened on Tuesday, February 24, 2026 due to luck of quorum.
AGM Information
2026-02-17 English
The Extraordinary General Meeting will be reconvened on Tuesday, February 24, 2026 due to luck of quorum.
Report Publication Announcement Q1 2026
2026-02-17 English
Immediate Report
Regulatory Filings
2026-01-28 English
Immediate Report
Report Publication Announcement Q1 2026
2026-01-28 English
6-K Filing
Regulatory Filings
2026-01-28 English
Subsidiary of the Company has filed a formal application with the competent Israeli court for the commencement of insolvency proceedings in accordance with the Israeli Insolvency and Economic Rehabil
Legal Proceedings Report
2026-01-25 English
Subsidiary of the Company has filed a formal application with the competent Israeli court for the commencement of insolvency proceedings in accordance with the Israeli Insolvency and Economic Rehabil
Report Publication Announcement
2026-01-25 English
Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency
Regulatory Filings
2026-01-25 Hebrew (modern)
Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency
Report Publication Announcement
2026-01-25 English
6-K Filing
Regulatory Filings
2026-01-23 English
6-K Filing
Regulatory Filings
2026-01-23 English
Immediate Report of Meeting
Proxy Solicitation & Information Statement
2026-01-13 English
Immediate Report of Meeting
Proxy Solicitation & Information Statement
2026-01-13 English
Signed a binding letter of intent (LOI) regarding a acquisition pf NeuroNOS - developing treatments for Autism
Regulatory Filings
2026-01-13 English
Signed a binding letter of intent (LOI) regarding a acquisition pf NeuroNOS - developing treatments for Autism
Report Publication Announcement Q1 2026
2026-01-13 English
6-K Filing
Regulatory Filings
2026-01-13 English
6-K Filing
Regulatory Filings
2026-01-13 English